Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

News und Analysen

NanoString to Present at the 2020 Baird Global Healthcare Conference
NanoString to Present at the 2020 Baird Global Healthcare Conference


NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced that the company’s management is scheduled to present

Agilent Announces Webcast for Investment Community
Agilent Announces Webcast for Investment Community


Agilent Technologies Inc. (NYSE: A) today announced the company will participate in the Wells Fargo 2020 Virtual Healthcare Conference on Wednesday, Sept. 9. A webcast of the event will be

Pfizer Invites Public to Register for Webcast of Virtual Investor Day on September 14 and 15, 2020
Pfizer Invites Public to Register for Webcast of Virtual Investor Day on September 14 and 15, 2020


Pfizer Inc. (NYSE: PFE) invites investors and the general public to access a live video webcast of its virtual Investor Day held over two days: Monday, September 14, 2020 from 1:00 p.m. EDT to 4:00

Pfizer Invites Public to Register for Webcast of Virtual Investor Day on September 14 and 15, 2020
Pfizer Invites Public to Register for Webcast of Virtual Investor Day on September 14 and 15, 2020


Pfizer Inc. (NYSE: PFE) invites investors and the general public to access a live video webcast of its virtual Investor Day held over two days: Monday, September 14, 2020 from 1:00 p.m. EDT to 4:00

Xencor and MD Anderson Enter Strategic Collaboration to Advance Investigational XmAb® Drug Candidates
Xencor and MD Anderson Enter Strategic Collaboration to Advance Investigational XmAb® Drug Candidates


Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies for the treatment of cancer and autoimmune diseases, and The University of Texas

Lantheus Holdings to Present at the Wells Fargo 2020 Virtual Healthcare Conference
Lantheus Holdings to Present at the Wells Fargo 2020 Virtual Healthcare Conference


Lantheus Holdings, Inc. (the “Company”) (NASDAQ: LNTH), the parent company of Lantheus Medical Imaging, Inc. and Progenics Pharmaceuticals, Inc., and a global leader in the development, manufacture

Illumina Collaborates With 54gene in the Creation of a World-Class Genomics Facility in Nigeria
Illumina Collaborates With 54gene in the Creation of a World-Class Genomics Facility in Nigeria


Illumina, Inc. (NASDAQ: ILMN) today announced a collaboration with 54gene, a health technology company whose mission is to advance precision medicine capabilities in Africa through research

Illumina Collaborates With 54gene in the Creation of a World-Class Genomics Facility in Nigeria
Illumina Collaborates With 54gene in the Creation of a World-Class Genomics Facility in Nigeria


Illumina, Inc. (NASDAQ: ILMN) today announced a collaboration with 54gene, a health technology company whose mission is to advance precision medicine capabilities in Africa through research

Illumina Collaborates With 54gene in the Creation of a World-Class Genomics Facility in Nigeria
Illumina Collaborates With 54gene in the Creation of a World-Class Genomics Facility in Nigeria


Illumina, Inc. (NASDAQ: ILMN) today announced a collaboration with 54gene, a health technology company whose mission is to advance precision medicine capabilities in Africa through research

Sangamo Therapeutics Announces Participation at Upcoming Investor Conferences
Sangamo Therapeutics Announces Participation at Upcoming Investor Conferences


Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, announced today that management will present at the following investor conferences:




  • Wells Fargo 2020 Virtual Healthcare

Texas A&M University, Humana Announce 2020 Healthcare Analytics Case Competition
Texas A&M University, Humana Announce 2020 Healthcare Analytics Case Competition


Mays Business School at Texas A&M University and leading health and well-being company Humana Inc. (NYSE: HUM) are launching the 2020 Humana-Mays Healthcare Analytics Case Competition to showcase

Premier Inc. Earns First Place in AHRQ Predictive Analytics Challenge
Premier Inc. Earns First Place in AHRQ Predictive Analytics Challenge


Premier Inc. (NASDAQ: PINC), a leading healthcare improvement company, today announced that the Agency for Healthcare Research and Quality (AHRQ) has selected it as a first-place winner in the

FDA Review of Approved Drug, Ubrogepant, Included DILIsym Simulations
FDA Review of Approved Drug, Ubrogepant, Included DILIsym Simulations


DILIsym Services, Inc., a Simulations Plus company (Nasdaq: SLP) and a leading provider of modeling and simulation software for pharmaceutical safety and efficacy, today announced that simulations

ICON plc to Present at Wells Fargo 2020 Virtual Global Healthcare Conference and Baird 2020 Global Healthcare Conference
ICON plc to Present at Wells Fargo 2020 Virtual Global Healthcare Conference and Baird 2020 Global Healthcare Conference


ICON plc, (NASDAQ: ICLR) a global provider of outsourced drug and device development and commercialisation services to pharmaceutical, biotechnology, medical device and government and public health

STAAR Surgical to Participate in Upcoming Investor Conferences
STAAR Surgical to Participate in Upcoming Investor Conferences


STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today announced that management will

Evotec: Neue Oxford-Partnerschaft!
Evotec: Neue Oxford-Partnerschaft!

Dank einer neuen Partnerschaft mit der Oxford Universität wird Evotec (WKN: 566480) zukünftig Zugriff auf Bioproben aus der Biobank "Quality in Organ Donation" erhalten. Darüber informierte das

LivaNova to Present at the Baird 2020 Global Healthcare Conference
LivaNova to Present at the Baird 2020 Global Healthcare Conference


LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology and innovation company, today announced Damien McDonald, Chief Executive Officer, will present at the Baird 2020 Global Healthcare

Agilent Announces SureSelect XT HS2 RNA Reagent Kit, a Library Prep and Target Enrichment Solution for RNA-Seq
Agilent Announces SureSelect XT HS2 RNA Reagent Kit, a Library Prep and Target Enrichment Solution for RNA-Seq


Agilent Technologies Inc. (NYSE: A) today announced the release of the SureSelect XT HS2 RNA Reagent Kit. This solution features a modular design that enables a simple and parallel approach for

Simulations Plus to Present at the LD 500 Virtual Conference
Simulations Plus to Present at the LD 500 Virtual Conference


Simulations Plus, Inc. (Nasdaq: SLP), the premier provider of simulation and modeling software and consulting services for pharmaceutical discovery and development, today announced that chief

Aimmune Therapeutics Enters Definitive Agreement with Sociétés des Produits Nestlé S.A., Part of Nestlé Health Science
Aimmune Therapeutics Enters Definitive Agreement with Sociétés des Produits Nestlé S.A., Part of Nestlé Health Science


Aimmune Therapeutics Inc. (Nasdaq: AIMT), a biopharmaceutical company developing and commercializing treatments for potentially life-threatening food allergies, today announced that it has entered

Abbott Laboratories: FDA-Zulassung für bahnbrechenden Corona-Test!
Abbott Laboratories: FDA-Zulassung für bahnbrechenden Corona-Test!

Der amerikanische Medizintechnik-Gigant Abbott Laboratories (WKN: 850103) war mit einem Plus von 7,85% auf 111,29 USD am Donnerstag einer der Tagesgewinner an der altehrwürdigen New York Stock

Quidel Provides Business Update at 13th Annual Piper Sandler Med-Tech and Diagnostic California Bus Tour; Another SARS Antigen Entrant Does Not Change Quidel’s Strategy
Quidel Provides Business Update at 13th Annual Piper Sandler Med-Tech and Diagnostic California Bus Tour; Another SARS Antigen Entrant Does Not Change Quidel’s Strategy


Quidel Corporation (NASDAQ: QDEL) (“Quidel”), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced today the following

Quidel to Present Today at 13th Annual Piper Sandler Med-Tech and Diagnostics California Bus Tour
Quidel to Present Today at 13th Annual Piper Sandler Med-Tech and Diagnostics California Bus Tour


Quidel Corporation (NASDAQ: QDEL) (“Quidel”), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced today that it will present

Agilent Sets the Standard in Customer Flexibility with Analytical Technology Subscription Model
Agilent Sets the Standard in Customer Flexibility with Analytical Technology Subscription Model


Agilent Technologies Inc. (NYSE: A) today announced its first-ever instrument subscription program, designed to meet the needs of customers with dynamic businesses who want the latest technology

FDA Approves FoundationOne® Liquid CDx to Serve as Rubraca® (rucaparib) Companion Diagnostic to Identify Eligible Patients with BRCA1/2-Mutant, Metastatic Castration-Resistant Prostate Cancer (mCRPC)
FDA Approves FoundationOne® Liquid CDx to Serve as Rubraca® (rucaparib) Companion Diagnostic to Identify Eligible Patients with BRCA1/2-Mutant, Metastatic Castration-Resistant Prostate Cancer (mCRPC)


Clovis Oncology, Inc. (NASDAQ: CLVS) announced today that the U.S. Food and Drug Administration (FDA) approved the FoundationOne® Liquid CDx, Foundation Medicine’s comprehensive liquid biopsy test